Radyasyona Organ ve Sistemlerin Tepkisi
Özet
Radyoterapinin tümörler üzerindeki lokal invaziv etkisini kontrol altına alırken normal dokuların korunması, tedavinin başarısını ve hastanın yaşam kalitesini doğrudan etkileyen kritik bir unsurdur. Dokuların ve organların radyasyona verdiği tepkiler; hücrelerin içsel radyoduyarlılığı, ait oldukları sistemlerin kinetiği, anatomik yapılanma şekilleri ve uygulanan fraksiyon şemaları ile yakından ilişkilidir. Casarett ve Michalowski gibi hiyerarşik veya esnek sınıflandırma modelleri, hücrelerin bölünme potansiyellerine göre hasar yanıt sürelerini ve tolerans sınırlarını açıklamaktadır. Erken dönem akut yan etkiler kök hücre hasarı kaynaklı olup proliferasyonu yüksek dokularda görülürken ve geri dönüşebilirken; parankim ile vasküler yapıların etkilendiği geç etkiler ilerleyici ve kalıcı niteliktedir. Organların fonksiyonel alt birimlerinin seri veya paralel dizilimi ile ışınlanan hacmin büyüklüğü, kabul edilebilir maksimum doz sınırlarını belirler. Tümöre yüksek doz ulaştırırken normal doku toksisitesini azaltmak amacıyla konvansiyonel yöntemlerin yanı sıra hiperfraksiyonasyon ve hipofraksiyonasyon gibi alternatif şemalar ile onarım mekanizmaları aktif şekilde yönetilmektedir.
Managing the local invasive nature of tumors through radiotherapy mandates a meticulous balance between target volume eradication and the preservation of surrounding normal tissues to prevent severe toxicities. The biological response of organs to ionizing radiation is fundamentally dictated by cellular radiosensitivity, tissue population kinetics, structural configuration, and the chosen fractionation regimen. Categorization models, such as Casarett's and Michalowski's classifications, illustrate how differentiated post-mitotic cells exhibit high radioresistance, whereas rapidly dividing stem cell populations show acute vulnerability. While early radiation effects manifest in highly proliferative tissues and remain largely reversible through stem cell regeneration, late effects involving stromal and vascular degradation are progressive and irreversible. Furthermore, the spatial organization of functional subunits into serial or parallel architectures determines the volume effect and tolerance thresholds of critical organs. To optimize the therapeutic ratio, clinical strategies employ altered fractionation schedules, including hyperfractionation and hypofractionation, which exploit cellular repair kinetics and biological time factors to achieve maximum tumor control with minimal normal tissue complication rates.
Referanslar
Mantovani A, Allavena P, Sica A, at al. Cancer-related inflammation. Nature. 2008; 454(7203):436-44.
Nuyts S. Defining the target for radiotherapy of head and neck cancer. Cancer Imaging. 2007; 7 Spec No A (Special issue A):S50-5.
Zhang C, Liang Z, Ma S, at al. Radiotherapy and Cytokine Storm: Risk and Mechanism. Front Oncol. 2021; 11:670464.
Hall EJ, Giaccia AJ. Radiobiology for the radiologist. Eighth edition; 2019.
Hayashi N, Monzen S, Ito K, Fujioka T, at al. Effects of ionizing radiation on proliferation and differentiation of mouse induced pluripotent stem cells. I.J Radiat Res. 2012;53(2):195-201
Koukourakis MI. Radiation damage and radioprotectants: new concepts in the era of molecular medicine. Br J Radiol. 2012; 85(1012): 313–330.
Jung H, Beck-Bornholdt HP, Svoboda V, et al. Quantification of late complications after radiation therapy. Radiother Oncol. 2001; 61(3):233-46.
Vogin G, Foray N. The law of Bergonié and Tribondeau: a nice formula for a first approximation. Int J Radiat Biol. 2013; 89(1):2-8.
Chang DS, Lasley FD, Das IJ, et al. In Basic Radiotherapy Physics and Biology; 2014.
Michalowski A. Effects of radiation on normal tissues: Hypothetical mechanisms and limitations of in situ assays of clonogenicity. Radiation and Environmental Biophysics. 1981; 19:157–172.
Ritter TA, Matuszak M, Chetty IJ, at al. Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials. Int J Radiat Oncol Biol Phys. 2017; 98(1): 34–36.
Hopewell JW, Trott KR. Volume effects in radiobiology as applied to radiotherapy. Radiother Oncol. 2000; 56(3):283-8.
Kogel AV, Joiner M. Basic Clinical Radiobiology 4th Edition; 2009
Arnold KM, Flynn NJ, Raben A, et al. The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules. Cancer Growth Metastasis. 2018; 11: 1179064418761639.
Holthusen H. Erfahrungen über die verträglichkeitsgrenze für röntgenstrahlen und deren nutzanwendung zur verhütung von schäden. Strahlenther Onkol. 1936; 57: 254–69.
Horiot JC, Le Fur R, N’Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol. 1992; 25: 231–41
Fu KK, Pak TF, Trotti A et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000; 48: 7–16.
Cosset JM, Mornex F, Eschwège F. Hypofractionation and radiotherapy: "the eternal return". Cancer Radiother. 2013; 17(5-6):355-62.
Beetz A, Messer G, Oppel T, et al. Induction of interleukin 6 by ionizing radiation in a human epithelial cell line: control by corticosteroids. Int J Radiat Biol. 1997; 72(1):33-43.
Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988; 27: 131–46.
